Phio Pharmaceuticals (PHIO) Stock Price, Quote, News & History | Benzinga

Phio Pharmaceuticals Corp (PHIO) Stock Price, Quote, News & History

PHIONASDAQ

Trade with Public

Trade with Public

$1.11

0.010.91%

Last update: Sep 2, 10:27 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$1.07

Close

-

Volume / Avg.

60.97K / 606.14K

Day Range

$1.07 - $1.12

52 Wk Range

0.81 - 4.19

Market Cap

$12.90M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

2.77%

Days to Cover

2.63

Recent Phio Pharmaceuticals Corp News

What's Going On With Tiny Cancer Biotech Phio Pharmaceuticals On Thursday?

Phio Pharma stock fell after a recent rally, despite strong Phase 1b trial results showing an 85% response rate. Analysts maintain Buy ratings as shares trade near 52-week lows.

Vandana Singh

Cancer Biotech Phio Pharmaceuticals Stock Surges As Trial Shows Tumor Clearance At Highest Dose In Skin Cancer Patients

Phio Pharmaceuticals shares rise after Phase 1b data shows strong safety and tumor clearance for its PH-762 skin cancer drug, with FDA talks planned in 2026.

Vandana Singh

Why Is Phio Pharmaceuticals Stock Soaring Today?

Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) are rising Monday after the company provided an update on an ongoing medical trial.

Alex Perry

Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results

Avi Kapoor

Nasdaq Gains Over 100 Points; Delta Air Lines Posts Upbeat Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.20M

Investing Cash Flow (TTM)

-4.00K

Financing Cash Flow (TTM)

14.43M

Free Cash Flow (TTM)

-12.21M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

2.22M

Analyst Trends and Forecast

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$391.28K

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.00

Earnings Yield % (TTM)

-118.89%

Earnings Yield % (FWD)

-56.22%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.08

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$13.00M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.07

Close

-

Volume / Avg.

60.97K / 606.14K

Day Range

$1.07 - $1.12

52 Wk Range

0.81 - 4.19

Market Cap

$12.90M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

2.77%

Days to Cover

2.63

About

Sector

Health Care

Industry

Biotechnology

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Phio Pharmaceuticals (PHIO) stock?

A

You can purchase shares of Phio Pharmaceuticals (NASDAQ:PHIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Phio Pharmaceuticals (PHIO) competitors?

A

Other companies in Phio Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Phio Pharmaceuticals (PHIO) stock?

A

Phio Pharmaceuticals has a consensus price target of $10.67.

Q

What is the current price for Phio Pharmaceuticals (PHIO)?

A

The stock price for Phio Pharmaceuticals (NASDAQ: PHIO) is $1.11 last updated September 2, 2026 at 10:27 AM EDT.

Q

Does Phio Pharmaceuticals (PHIO) pay a dividend?

A

There are no upcoming dividends for Phio Pharmaceuticals.

Q

When is Phio Pharmaceuticals (NASDAQ:PHIO) reporting earnings?

A

Phio Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Phio Pharmaceuticals (PHIO) going to split?

A

There is no upcoming split for Phio Pharmaceuticals.

Q

What sector and industry does Phio Pharmaceuticals (PHIO) operate in?

A

Phio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.